Search results for:
donanemab
donanemab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Donanemab-azbt |
SOLUTION, INTRAVENOUS |
17.5 mg/mL (20 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Feb. 21, 2026
UNC Health
System Formulary Restriction:
Use of donanemab injection is restricted to outpatient/clinic encounters only (i.e., no inpatient use) in patients who meet the following criteria: